Traditionally, estrogen receptor (ER), progesterone receptor (PR) and Her2 have been used to classify breast cancer into three subtypes: positive for hormonal receptors (ER+), Her2+, and triple negative (TNBC) without these receptors. This evidence concerns the gene ERBB2 and breast cancer.